The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-((1S,2S)-2-hydroxycyclohexyl)-1-(4-methoxybenzyl)-1H-pyrrolo[3,2-b]pyridine-3-carboxamide ID: ALA4546244
PubChem CID: 117937668
Max Phase: Preclinical
Molecular Formula: C22H25N3O3
Molecular Weight: 379.46
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc(Cn2cc(C(=O)N[C@H]3CCCC[C@@H]3O)c3ncccc32)cc1
Standard InChI: InChI=1S/C22H25N3O3/c1-28-16-10-8-15(9-11-16)13-25-14-17(21-19(25)6-4-12-23-21)22(27)24-18-5-2-3-7-20(18)26/h4,6,8-12,14,18,20,26H,2-3,5,7,13H2,1H3,(H,24,27)/t18-,20-/m0/s1
Standard InChI Key: KQYFNYPILBBWOB-ICSRJNTNSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
28.1683 -2.5052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7319 -3.5453 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7307 -4.3648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.4388 -4.7738 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.4370 -3.1364 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.1456 -3.5417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.1504 -4.3603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.9304 -4.6087 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.4078 -3.9436 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.9227 -3.2842 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1874 -5.3844 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.9878 -5.5497 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2396 -6.3254 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0390 -6.4909 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.5832 -5.8801 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3224 -5.1012 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5235 -4.9394 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3838 -6.0442 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.6418 -6.8196 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.6163 -1.9027 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.9662 -2.3284 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.8621 -1.1233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6657 -0.9510 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.9123 -0.1756 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3631 0.4367 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.5639 0.2568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.3139 -0.5258 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5157 -0.7011 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 3 2 0
3 4 1 0
4 7 2 0
6 5 2 0
5 2 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 2 0
10 6 1 0
10 1 1 0
8 11 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
15 18 1 0
18 19 1 0
1 20 1 0
1 21 2 0
22 20 1 6
22 23 1 0
22 27 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
27 28 1 1
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 379.46Molecular Weight (Monoisotopic): 379.1896AlogP: 3.13#Rotatable Bonds: 5Polar Surface Area: 76.38Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 3.48CX LogP: 2.83CX LogD: 2.83Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.71Np Likeness Score: -0.79
References 1. Wold EA, Chen J, Cunningham KA, Zhou J.. (2018) Allosteric Modulation of Class A GPCRs: Targets, Agents, and Emerging Concepts., 62 (1): [PMID:30106578 ] [10.1021/acs.jmedchem.8b00875 ]